Pressure Ulcer Prevention Market By Product Type (Dynamic Support Surfaces, Static Support Surfaces, Dressings, Skin Care Products and Creams, Positioners and Protectors, Pressure Monitoring and Detection Systems); By Prevention Approach (Pressure Redistribution Solutions, Skin Protection and Moisture Management, Patient Positioning and Repositioning Solutions, Risk Assessment and Monitoring Solutions, Nutritional Support Products); By End User (Hospitals and Ambulatory Surgery Centers, Long-Term Care Facilities and Nursing Homes, Home Healthcare Settings, Clinics and Rehabilitation Centers, Other Care Settings); By Patient Type (Geriatric Patients, Patients with Limited Mobility, Intensive Care Unit Patients, Surgical and Postoperative Patients, Spinal Cord Injury Patients); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

How Is the Pressure Ulcer Prevention Market Positioned for Growth and What Clinical Developments Are Influencing Its Future?

The Global Pressure Ulcer Prevention Market was valued at USD 1.18 billion in 2025 and is projected to reach USD 1.61 billion by 2032, expanding at a CAGR of 4.5% during 2026–2032, according to Strategic Market Research.

 

Preventing pressure ulcers focuses on reducing pressure, protecting skin, and supporting overall health. Reposition regularly by changing bed position every 1–2 hours and shifting weight frequently when seated to maintain blood flow. Avoid dragging the body during movement, and use pillows or positioning aids to protect vulnerable areas.

 

Maintain clean, dry skin and inspect pressure points such as the tailbone, hips, and heels for redness or changes. Use moisture barrier creams when needed and avoid massaging irritated areas.

 

Specialized foam, gel, or air mattresses and cushions help distribute pressure and reduce injury risk. Avoid donut cushions, which can increase pressure around tissues. A balanced diet with adequate protein and proper hydration supports skin health and healing.

 

Leading pressure ulcer prevention companies provide advanced support surfaces, protective dressings, and skin care solutions to reduce injury risk. Mölnlycke Health Care offers prophylactic solutions such as Mepilex Border foam dressings designed for pressure points. Smith+Nephew provides Allevyn Complete Care dressings and Secura skin protection products. Arjo specializes in pressure redistribution systems, including Auralis therapy mattresses and AtmosAir Velaris support surfaces. ConvaTec develops Aquacel Foam and ConvaFoam dressings for moisture and friction management. 3M supplies Tegaderm Silicone Foam, Cavilon barrier products, and Kerrapro silicone pressure-reducing pads.

 

Strategic Insights and Core Findings Shaping the Pressure Ulcer Prevention Market Landscape

By Product Type

• Dynamic Support Surfaces — 31.0% of the market, USD 365.8 million in 2025, projected to grow at a CAGR of 5.2% during 2026–2032. Largest product category supported by widespread use of alternating-pressure, low-air-loss and powered pressure redistribution systems in high-risk hospital and long-term care populations.

• Static Support Surfaces — 24.0% of the market, USD 283.2 million in 2025, projected to grow at a CAGR of 3.7% during 2026–2032. Established prevention category used across general wards, rehabilitation facilities and nursing homes due to simpler deployment and lower infrastructure requirements.

• Dressings — 16.0% of the market, USD 188.8 million in 2025, projected to grow at a CAGR of 4.4% during 2026–2032. Recurring consumable segment supported by prophylactic silicone foam products designed for sacral and heel protection in selected high-risk patients.

• Skin Care Products & Creams — 11.0% of the market, USD 129.8 million in 2025, projected to grow at a CAGR of 3.8% during 2026–2032. Complementary prevention category focused on moisture management, skin barrier protection and reduction of friction-related damage.

• Positioners & Protectors — 10.0% of the market, USD 118.0 million in 2025, projected to grow at a CAGR of 4.1% during 2026–2032. Supporting segment strengthened by increased use of heel boots, wedges, fluidized positioners and turning systems.

• Pressure Monitoring and Detection Systems — 8.0% of the market, USD 94.4 million in 2025, projected to grow at a CAGR of 7.1% during 2026–2032. Fastest-growing technology category supported by digital mobility tracking and prevention workflow integration.

 

By Prevention Approach

• Pressure Redistribution Solutions — 34.0% of the market, USD 401.2 million in 2025, projected to grow at a CAGR of 4.8% during 2026–2032. Leading prevention approach based on continuous use of mattresses, overlays, cushions and therapeutic surfaces.

• Skin Protection & Moisture Management — 24.0% of the market, USD 283.2 million in 2025, projected to grow at a CAGR of 4.3% during 2026–2032. Important preventive pathway using barrier products and protective dressings to maintain skin integrity.

• Patient Positioning & Repositioning Solutions — 17.0% of the market, USD 200.6 million in 2025, projected to grow at a CAGR of 4.2% during 2026–2032. Essential care component focused on reducing prolonged pressure exposure through positioning assistance.

• Risk Assessment & Monitoring Solutions — 15.0% of the market, USD 177.0 million in 2025, projected to grow at a CAGR of 5.8% during 2026–2032. Expanding technology category using digital tools and structured monitoring approaches.

• Nutritional Support Products — 10.0% of the market, USD 118.0 million in 2025, projected to grow at a CAGR of 3.4% during 2026–2032. Complementary prevention category used within broader patient-care programs.

 

By End User

• Hospitals & Ambulatory Surgery Centers — 42.0% of the market, USD 495.6 million in 2025, projected to grow at a CAGR of 4.9% during 2026–2032. Largest end-user segment due to extensive use of advanced surfaces, prevention dressings and monitoring technologies.

• Long-Term Care Facilities & Nursing Homes — 26.0% of the market, USD 306.8 million in 2025, projected to grow at a CAGR of 4.1% during 2026–2032. Significant segment driven by extended patient exposure and continued need for pressure-management solutions.

• Home Healthcare Settings — 14.0% of the market, USD 165.2 million in 2025, projected to grow at a CAGR of 6.0% during 2026–2032. Fastest-growing care environment as selected prevention technologies move into community-based care.

• Clinics & Rehabilitation Centers — 10.0% of the market, USD 118.0 million in 2025, projected to grow at a CAGR of 4.3% during 2026–2032. Supported by patients recovering from surgery, neurological conditions and mobility-limiting injuries.

• Other Care Settings — 8.0% of the market, USD 94.4 million in 2025, projected to grow at a CAGR of 3.9% during 2026–2032. Includes specialized institutional environments using prevention products within smaller procurement pathways.

 

By Patient Type

• Geriatric Patients — 38.0% of the market, USD 448.4 million in 2025, projected to grow at a CAGR of 4.2% during 2026–2032. Largest patient group due to higher prevalence of reduced mobility, fragile skin and prolonged healthcare exposure.

• Patients with Limited Mobility — 27.0% of the market, USD 318.6 million in 2025, projected to grow at a CAGR of 4.6% during 2026–2032. Major prevention population requiring continuous pressure redistribution and repositioning support.

• Intensive Care Unit Patients — 18.0% of the market, USD 212.4 million in 2025, projected to grow at a CAGR of 5.1% during 2026–2032. High-value segment due to complex conditions involving sedation, ventilation, immobility and prolonged hospitalization.

• Surgical and Postoperative Patients — 10.0% of the market, USD 118.0 million in 2025, projected to grow at a CAGR of 4.0% during 2026–2032. Supported by prevention requirements during lengthy procedures and recovery periods.

• Spinal Cord Injury Patients — 7.0% of the market, USD 82.6 million in 2025, projected to grow at a CAGR of 4.5% during 2026–2032. Long-term prevention segment requiring specialized pressure management and monitoring approaches.

 

Comprehensive Segmentation of the Pressure Ulcer Prevention Market by Product Categories, Clinical Prevention Strategies, Care Settings, and Patient Risk Profiles

Dynamic support surfaces accounted for 31.0% of the pressure ulcer prevention market, representing USD 365.8 million in 2025, and are projected to expand at a CAGR of 5.2% during 2026–2032. These powered systems represent the largest product category because they actively modify pressure distribution through alternating-pressure technology, low-air-loss systems and automated pressure adjustment. They are commonly used for intensive care patients, individuals with limited mobility and patients requiring higher levels of pressure redistribution. Clinical guidance recognizes active and reactive support surfaces as important components of prevention programs, with selection based on patient risk, mobility, body characteristics and requirements for pressure redistribution, shear reduction and microclimate management. Companies such as Arjo and Stryker provide advanced support surface portfolios designed for acute-care environments where pressure management must be combined with workflow efficiency and patient handling requirements.

Static support surfaces represented 24.0% of the market, equivalent to USD 283.2 million in 2025, and are expected to grow at a CAGR of 3.7% during 2026–2032. Foam-based and non-powered pressure redistribution surfaces continue to represent a widely deployed prevention approach because they can be installed across general hospital beds, rehabilitation facilities and long-term care environments without additional pump infrastructure. International prevention guidance recommends appropriate pressure redistribution surfaces for individuals at risk, with high-specification foam surfaces remaining an important option across many care settings. Companies such as Baxter/Hillrom integrate static pressure management technologies into broader hospital-bed platforms, allowing healthcare providers to combine patient positioning, mobility support and pressure prevention within a single equipment ecosystem.

Dressings accounted for 16.0% of the market, representing USD 188.8 million in 2025, and are projected to expand at a CAGR of 4.4% during 2026–2032. Preventive silicone foam dressings represent a recurring consumable category used primarily in high-risk anatomical areas such as the sacrum and heels. Their commercial importance comes from repeat utilization across intensive care units, surgical settings and immobile patient pathways. Clinical recommendations position preventive dressings as an additional intervention alongside repositioning and pressure redistribution rather than a replacement for support surfaces. Companies such as Smith+Nephew and Mölnlycke compete through products including ALLEVYN LIFE and Mepilex Border formats that are designed around anatomical protection, skin compatibility and prevention workflows.

Skin care products and creams accounted for 11.0% of the market, representing USD 129.8 million in 2025, and are projected to grow at a CAGR of 3.8% during 2026–2032. These products support prevention protocols by protecting vulnerable skin from moisture exposure, friction and irritation, particularly among patients with incontinence, reduced mobility or prolonged hospitalization. Their role is complementary because skin protection programs are generally implemented together with pressure redistribution and repositioning practices rather than as standalone solutions.

Positioners and protectors represented 10.0% of the market, equivalent to USD 118.0 million in 2025, and are expected to expand at a CAGR of 4.1% during 2026–2032. Heel boots, wedges, fluidized positioners and turning systems address localized pressure exposure and support individualized repositioning strategies. Companies such as Mölnlycke combine positioning products with preventive dressings through bundled approaches that address multiple pressure-risk locations across the patient body.

Pressure monitoring and detection systems accounted for 8.0% of the market, representing USD 94.4 million in 2025, and are forecast to expand at the fastest product-level CAGR of 7.1% during 2026–2032. These technologies add a digital layer to prevention by tracking mobility, patient position and compliance with turning protocols. Smith+Nephew's LEAF Patient Monitoring System illustrates this transition by connecting wearable sensing technology with clinical workflows, allowing caregivers to monitor patient movement and repositioning requirements.

 

Comprehensive Breakdown of the Pressure Ulcer Prevention Market Across Key Prevention Approaches and Clinical Intervention Strategies

Pressure redistribution solutions represented 34.0% of the market, equivalent to USD 401.2 million in 2025, and are projected to expand at a CAGR of 4.8% during 2026–2032. This segment leads because mattresses, overlays, cushions and therapeutic surfaces form the foundation of most hospital prevention programs. Support surfaces are selected according to patient risk, body weight distribution, mobility limitations and the need for pressure reduction, shear control and microclimate management.

Skin protection and moisture management accounted for 24.0% of the market, representing USD 283.2 million in 2025, and are expected to grow at a CAGR of 4.3% during 2026–2032. Barrier films, protective creams and moisture-control products support prevention pathways by maintaining skin integrity in patients exposed to prolonged moisture or friction. These products are particularly relevant in intensive care, elderly care and long-term-care environments.

Patient positioning and repositioning solutions represented 17.0% of the market, equivalent to USD 200.6 million in 2025, and are projected to grow at a CAGR of 4.2% during 2026–2032. Turning aids, wedges, heel-offloading devices and positioning systems remain important because advanced mattresses do not eliminate the need for individualized repositioning practices. Clinical guidelines continue to emphasize repositioning as part of comprehensive prevention strategies.

Risk assessment and monitoring solutions accounted for 15.0% of the market, representing USD 177.0 million in 2025, and are expected to expand at a CAGR of 5.8% during 2026–2032. Hospitals are increasingly incorporating digital documentation and monitoring tools to improve visibility into patient mobility and prevention compliance. These technologies support quality improvement programs by linking clinical actions with measurable workflow information.

Nutritional support products represented 10.0% of the market, equivalent to USD 118.0 million in 2025, and are projected to grow at a CAGR of 3.4% during 2026–2032. These products support prevention programs for patients with nutritional risk factors affecting tissue tolerance. Their commercial role is generally integrated into broader patient-care pathways rather than functioning as a standalone prevention technology.

 

Care Settings and Patient Populations as Key Demand Drivers in the Pressure Ulcer Prevention Market

Hospitals and ambulatory surgery centers accounted for 42.0% of the pressure ulcer prevention market, representing USD 495.6 million in 2025, and are projected to expand at a CAGR of 4.9% during 2026–2032. This segment represents the largest commercial pathway because acute-care environments require a broad combination of dynamic support surfaces, prophylactic dressings, patient-positioning products, integrated beds and monitoring technologies. Hospitals manage some of the highest-risk populations, including intensive care patients, surgical patients and individuals with prolonged immobility. AHRQ identifies pressure ulcers as a significant hospital patient-safety issue, with more than 2.5 million people developing pressure ulcers annually in the United States, reinforcing the importance of structured prevention programs and hospital workflow integration. Companies such as Stryker, Baxter/Hillrom and Arjo compete by combining specialty surfaces with broader acute-care equipment portfolios.

Long-term care facilities and nursing homes accounted for 26.0% of the market, representing USD 306.8 million in 2025, and are projected to expand at a CAGR of 4.1% during 2026–2032. This segment is supported by the extended duration of patient exposure, higher prevalence of mobility limitations and the requirement for continuous prevention protocols. Nursing homes frequently use pressure redistribution mattresses, cushions, skin protection products and electronic monitoring approaches because residents may require long-duration support. AHRQ highlights that pressure ulcers continue to be a serious challenge in nursing homes and are associated with increased infection risk, longer hospitalization and higher morbidity. Digital prevention programs and structured assessment tools are becoming more relevant as long-term care providers focus on measurable quality outcomes.

Home healthcare settings represented 14.0% of the market, equivalent to USD 165.2 million in 2025, and are expected to grow at the fastest end-user CAGR of 6.0% during 2026–2032. The segment includes home-use support surfaces, pressure-relieving cushions, heel protection products, skin barriers and selected rental-based equipment. Expansion of home-based care pathways is creating a need for prevention technologies that can function with limited caregiver infrastructure compared with hospitals. Companies providing portable surfaces and home-care equipment benefit from solutions designed for easier installation, maintenance and patient handling.

Clinics and rehabilitation centers accounted for 10.0% of the market, representing USD 118.0 million in 2025, and are projected to expand at a CAGR of 4.3% during 2026–2032. Rehabilitation facilities manage patients recovering from neurological conditions, trauma, surgery and mobility-limiting disorders where pressure redistribution remains important during recovery. Product selection in these settings often focuses on cushions, positioning systems and adaptable support surfaces that support longer rehabilitation pathways.

Other care settings accounted for 8.0% of the market, representing USD 94.4 million in 2025, and are expected to expand at a CAGR of 3.9% during 2026–2032. This category includes specialized residential facilities and institutional environments where prevention technologies are used within smaller procurement pathways. These settings typically prioritize practical solutions that balance prevention performance, maintenance requirements and operating costs.

 

Patient Risk Profiles and Care Settings Driving the Adoption of Tailored Pressure Ulcer Prevention Technologies

Geriatric patients accounted for 38.0% of the pressure ulcer prevention market, representing USD 448.4 million in 2025, and are projected to expand at a CAGR of 4.2% during 2026–2032. Older adults represent the largest patient category because aging is commonly associated with reduced mobility, thinner skin, chronic disease burden and longer periods of healthcare exposure. This patient group drives utilization of support surfaces, preventive dressings, skin protection products and repositioning solutions across hospitals and long-term care environments.

Patients with limited mobility represented 27.0% of the market, equivalent to USD 318.6 million in 2025, and are expected to grow at a CAGR of 4.6% during 2026–2032. This category includes patients affected by neurological disorders, musculoskeletal limitations, severe illness and recovery-related immobility. Prevention pathways for these patients typically require a combination of pressure redistribution, repositioning assistance and monitoring because independent movement is reduced.

Intensive care unit patients accounted for 18.0% of the market, representing USD 212.4 million in 2025, and are projected to expand at the fastest patient-type CAGR of 5.1% during 2026–2032. ICU patients often experience multiple risk factors including mechanical ventilation, sedation, hemodynamic instability and prolonged bed rest. These factors support use of advanced dynamic surfaces, prophylactic dressings and digital monitoring systems. CMS continues to track pressure injury as a hospital harm measure for inpatient populations, reflecting the clinical importance of prevention in acute-care settings.

Surgical and postoperative patients represented 10.0% of the market, representing USD 118.0 million in 2025, and are expected to grow at a CAGR of 4.0% during 2026–2032. Long procedures, anesthesia-related immobility and restricted postoperative movement create specific prevention requirements. Hospitals increasingly incorporate prophylactic dressings, pressure redistribution surfaces and repositioning protocols into perioperative care pathways.

Spinal cord injury patients accounted for 7.0% of the market, representing USD 82.6 million in 2025, and are projected to expand at a CAGR of 4.5% during 2026–2032. These patients often require long-term pressure management because sensory impairment and reduced mobility increase vulnerability to pressure-related tissue damage. Rehabilitation centers and home-care providers represent important utilization settings for specialized cushions, positioning products and monitoring solutions.

 

Regional Growth Dynamics and Evolving Adoption Patterns Shaping the Pressure Ulcer Prevention Market Landscape

North America accounted for 39.0% of the pressure ulcer prevention market, representing USD 460.2 million in 2025, and is projected to expand at a CAGR of 4.8% during 2026–2032. The region has one of the most developed prevention ecosystems because hospital quality measurement, reimbursement policies and patient-safety initiatives directly influence adoption of prevention technologies. The United States healthcare system evaluates pressure injury outcomes through quality frameworks such as CMS hospital harm measures and AHRQ patient safety indicators. Companies such as Stryker, Baxter/Hillrom, Arjo, Smith+Nephew and Solventum maintain broad commercial presence across hospital and post-acute care environments.

Europe represented 31.0% of the market, equivalent to USD 365.8 million in 2025, and is expected to expand at a CAGR of 4.5% during 2026–2032. European healthcare systems combine clinical guideline adoption with centralized procurement structures, supporting demand for complete prevention pathways rather than individual products. Companies such as Arjo and Mölnlycke have developed strong regional positions through support surfaces, wound-care products and bundled prevention approaches. Rental models and managed equipment services are also relevant in markets where hospitals optimize capital expenditure and equipment availability.

Asia Pacific accounted for 20.0% of the market, representing USD 236.0 million in 2025, and is projected to expand at a CAGR of 4.2% during 2026–2032. The region is influenced by expanding hospital infrastructure, aging populations and improving recognition of hospital-acquired complications. Healthcare providers are gradually adopting advanced support surfaces and prevention consumables alongside broader improvements in nursing protocols and hospital quality management.

Latin America represented 6.0% of the market, equivalent to USD 70.8 million in 2025, and is expected to grow at a CAGR of 3.8% during 2026–2032. Market development is linked to hospital modernization, availability of imported medical devices and improving prevention practices within larger healthcare institutions. Procurement remains concentrated among major hospitals and private healthcare networks.

Middle East & Africa accounted for 4.0% of the market, representing USD 47.2 million in 2025, and is projected to expand at a CAGR of 4.0% during 2026–2032. Healthcare infrastructure development, new hospital capacity and modernization of critical-care facilities support adoption of pressure prevention technologies, particularly in tertiary hospitals.

 

Evolving Competitive Dynamics and Strategic Positioning in the Pressure Ulcer Prevention Market Landscape

The competitive landscape is shaped by product portfolio breadth, prevention pathway integration, clinical evidence, hospital workflow compatibility and service capability. Companies compete across dynamic support surfaces, advanced wound-care products, digital monitoring platforms, patient-positioning systems and rental-based equipment models. Competitive differentiation is increasingly moving toward complete prevention ecosystems that combine pressure redistribution, skin protection, repositioning support and measurable patient-care outcomes.

Arjo
Arjo competes across pressure injury prevention surfaces, medical beds, patient handling systems and healthcare services. Its portfolio includes Auralis, Auralis Plus, AtmosAir Velaris, Alpha Active and Nimbus pressure redistribution solutions designed for different patient-risk categories. Auralis uses alternating-pressure technology combined with reactive continuous low pressure, while Auralis Plus adds micro-air-loss capability for patients requiring enhanced skin microclimate management. The company has also strengthened its service-based model through rental capabilities, including the acquisition of GerroMed Pflege- und Medizintechnik in Germany, supporting equipment availability, fleet management and recurring service revenue.

Smith+Nephew
Smith+Nephew maintains a strong position through advanced wound-management products and digital prevention technologies. Its ALLEVYN LIFE portfolio includes prophylactic foam dressings designed for areas such as the sacrum and heel, supporting prevention protocols in high-risk patients. The company has expanded beyond consumables through the LEAF Patient Monitoring System, a wearable technology platform that tracks patient movement and positioning status to support clinical workflows. This combination allows Smith+Nephew to participate in both recurring prevention consumables and digital monitoring solutions.

Mölnlycke Health Care
Mölnlycke competes through integrated pressure injury prevention bundles combining dressings, positioning and off-loading products. Its Mepilex Border Sacrum and Mepilex Border Heel products are used within prevention pathways focused on high-risk anatomical locations. The company's broader Head-to-Heel approach combines prophylactic dressings with products such as Z-Flo Fluidized Positioners, Tortoise Turning and Positioning System and Z-Flex Heel Boot. This strategy positions Mölnlycke around complete prevention protocols rather than individual wound-care products.

Stryker
Stryker participates primarily through acute-care support surfaces and specialty hospital equipment. Its IsoTour surface combines gel-based pressure redistribution with optional low-air-loss functionality, while IsoAir provides active pressure management through sensing, immersion and microclimate control technologies. The company also integrates economic value considerations into selected support-surface programs by linking equipment solutions with hospital goals related to specialty-surface utilization and pressure-injury outcomes.

Baxter / Hillrom
Baxter's Hillrom portfolio combines hospital beds, therapeutic surfaces and patient-care technologies. Centrella Smart+ integrates bed functionality with pressure redistribution and microclimate-management capabilities for medical-surgical environments, while Envella Air Fluidized Therapy Bed addresses higher-acuity pressure injury prevention needs. The company's position is supported by the integration of prevention technology with broader hospital workflow, patient mobility and care-delivery requirements.

Solventum
Solventum participates primarily through skin protection and advanced wound-care consumables. The company's Tegaderm Silicone Border Foam Dressing supports wound-care and pressure injury prevention pathways, while Cavilon skin barrier products address moisture exposure, friction and shear-related skin vulnerability. This positions Solventum as a complementary supplier within prevention programs focused on maintaining skin integrity alongside pressure redistribution strategies.

 

Strategic Drivers Reshaping the Future Trajectory of the Pressure Ulcer Prevention Market

The future direction of the pressure ulcer prevention market will depend on how effectively companies integrate physical products, digital monitoring and service models into complete prevention pathways. Hospitals and care providers are increasingly evaluating solutions based on workflow impact, evidence quality, maintenance requirements and the ability to support measurable prevention programs.

Support surfaces will continue to represent the foundation of the market, but differentiation is moving beyond basic pressure redistribution. Advanced systems increasingly combine automated pressure adjustment, low-air-loss technology, microclimate control, patient weight distribution analysis and integration with hospital-bed platforms. Companies with broader equipment ecosystems can position prevention technologies as part of wider patient-care infrastructure rather than individual devices.

Consumable categories such as prophylactic dressings and skin protection products will continue to benefit from recurring utilization patterns. However, competitive positioning will depend on clinical evidence, anatomical design, ease of application and integration into standardized prevention protocols. Preventive dressings are increasingly evaluated alongside support surfaces and repositioning practices rather than as isolated interventions.

Digital monitoring represents one of the most significant technology shifts within the market. Wearable sensors and workflow platforms provide hospitals with visibility into patient movement, repositioning compliance and prevention activities. As healthcare systems place greater emphasis on measurable quality outcomes, digital prevention tools can become an important component of hospital safety programs.

Rental and managed-service models are also becoming strategically important, particularly for high-cost dynamic surfaces and specialty equipment. Healthcare providers may prefer flexible access models for equipment used selectively across high-risk patients rather than purchasing every advanced surface outright. Companies with strong logistics, maintenance and fleet-management capabilities can create additional value beyond product manufacturing.

 

Pressure Ulcer Prevention Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 1.18 Billion
Revenue Forecast in 2032	USD 1.61 Billion
Overall Growth Rate	CAGR of 4.5% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Prevention Approach, By End User, By Patient Type, By Geography
By Product Type	Dynamic Support Surfaces, Static Support Surfaces, Dressings, Skin Care Products and Creams, Positioners and Protectors, Pressure Monitoring and Detection Systems
By Prevention Approach	Pressure Redistribution Solutions, Skin Protection and Moisture Management, Patient Positioning and Repositioning Solutions, Risk Assessment and Monitoring Solutions, Nutritional Support Products
By End User	Hospitals and Ambulatory Surgery Centers, Long-Term Care Facilities and Nursing Homes, Home Healthcare Settings, Clinics and Rehabilitation Centers, Other Care Settings
By Patient Type	Geriatric Patients, Patients with Limited Mobility, Intensive Care Unit Patients, Surgical and Postoperative Patients, Spinal Cord Injury Patients
By Geography	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Growing geriatric and limited-mobility populations, hospital pressure-injury prevention programs, adoption of advanced support surfaces, recurring demand for prophylactic dressings and skin protection products, expansion of digital monitoring and home healthcare
Customization Option	Available upon request